Enliven Therapeutics
ELVN
#4135
Rank
NZ$5.35 B
Marketcap
NZ$73.02
Share price
0.86%
Change (1 day)
96.30%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$26.86 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are NZ$26.86 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$28.6 M1.37%
2024-12-31NZ$28.21 M-31.26%
2023-12-31NZ$41.05 M-83.72%
2022-12-31NZ$0.25 B10.27%
2021-12-31NZ$0.22 B9.06%
2020-12-31NZ$0.20 B